Single Dose of Hallucinogenic Drug Psilocybin Relieves Anxiety & Depression in Patients with Advanced Cancer
When combined with psychological counseling, a single dose of a mind-altering compound contained in psychedelic mushrooms significantly lessens mental anguish in distressed cancer patients for months at a time, according to results of a clinical trial led by researchers at NYU Langone Medical Center.
University at Buffalo Jacobs School of Medicine and Biomedical Sciences: New Clues to Myelination Could Help Identify Ways to Intervene in Neurodegenerative Diseases